Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

Here are some of the major companies whose stocks moved on the week’s news.

Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...